Bone Density Conservation Agents
"Bone Density Conservation Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.
| Descriptor ID |
D050071
|
| MeSH Number(s) |
D27.505.696.242
|
| Concept/Terms |
Antiresorptive Agents- Antiresorptive Agents
- Bone Resorption Inhibitors
- Inhibitors, Bone Resorption
- Resorption Inhibitors, Bone
- Bone Resorption Inhibitory Agents
- Antiresorptive Drugs
|
Below are MeSH descriptors whose meaning is more general than "Bone Density Conservation Agents".
Below are MeSH descriptors whose meaning is more specific than "Bone Density Conservation Agents".
This graph shows the total number of publications written about "Bone Density Conservation Agents" by people in this website by year, and whether "Bone Density Conservation Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 1 | 2 |
| 2007 | 3 | 0 | 3 |
| 2008 | 0 | 1 | 1 |
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 1 | 3 |
| 2014 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone Density Conservation Agents" by people in Profiles.
-
Strong AL, Ohlstein JF, Jiang Q, Zhang Q, Zheng S, Boue SM, Elliott S, Gimble JM, Burow ME, Wang G, Bunnell BA. Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms. Stem Cell Res Ther. 2014 Aug 28; 5(4):105.
-
Clunie GP, Ginawi A, O'Conner P, Bearcroft PW, Garber SJ, Bhagat S, Grainger A, Gaston JS. An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis. Ann Rheum Dis. 2014 Jun; 73(6):1273-4.
-
Díaz-Correa LM, Ramírez-García LM, Castro-Santana LE, Vilá LM. Osteoporosis knowledge in patients with a first fragility fracture in Puerto Rico. Bol Asoc Med P R. 2014; 106(1):6-10.
-
López-López L, Vilá LM. Atypical subtrochanteric fractures associated with long-term use of bisphosphonates. P R Health Sci J. 2011 Dec; 30(4):211.
-
Reicks M, Degeneffe D, Ghosh K, Bruhn C, Goodell LS, Gunther C, Auld G, Ballejos M, Boushey C, Cluskey M, Misner S, Olson B, Wong S, Zaghloul S. Parent calcium-rich-food practices/perceptions are associated with calcium intake among parents and their early adolescent children. Public Health Nutr. 2012 Feb; 15(2):331-40.
-
Reicks M, Ballejos ME, Goodell LS, Gunther C, Richards R, Wong SS, Auld G, Boushey CJ, Bruhn C, Cluskey M, Misner S, Olson B, Zaghloul S. Individual and family correlates of calcium-rich food intake among parents of early adolescent children. J Am Diet Assoc. 2011 Mar; 111(3):376-84.
-
Miller JE, Kovesdy CP, Norris KC, Mehrotra R, Nissenson AR, Kopple JD, Kalantar-Zadeh K. Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. Am J Nephrol. 2010; 32(5):403-13.
-
Lee E, Maneno MK, Wutoh AK, Zuckerman IH. Long-term effect of the Women's Health Initiative study on antiosteoporosis medication prescribing. J Womens Health (Larchmt). 2010 May; 19(5):847-54.
-
Yang YJ, Martin BR, Boushey CJ. Development and evaluation of a brief calcium assessment tool for adolescents. J Am Diet Assoc. 2010 Jan; 110(1):111-5.
-
Wong SS, Boushey CJ, Novotny R, Gustafson DR. Evaluation of a computerized food frequency questionnaire to estimate calcium intake of Asian, Hispanic, and non-Hispanic white youth. J Am Diet Assoc. 2008 Mar; 108(3):539-43.